Sequenced Treatment Alternatives to Relieve Depression (STAR*D) - Part 1: Study design

Journal of Psychosocial Nursing and Mental Health Services

Volumn 46, Issue 9, 2008, Pages 21-24

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54049126154     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20080901-06     Document Type: Short Survey

References (12)

1. Fava, M., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Alpert, J.E., McGrath, P.J., et al. (2006). A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D report. American Journal of Psychiatry, 163, 1161-1172.
2. Howland, R.H., & Thase, M.E. (1999). What to do with SSRI nonresponders? Journal of Practical Psychiatry and Behavioral Health, 5, 216-223.
3. McGrath, P.J., Stewart, J.W., Fava, M., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., et al. (2006). Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: A STAR*D report. American Journal of Psychiatry, 163, 1531-1541.
4. Nierenberg, A.A., Fava, M., Trivedi, M.H., Wisniewski, S.R., Thase, M.E., McGrath, P.J., et al. (2006). A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report. American Journal of Psychiatry, 163, 1519-1530.
5. Rush, A.J., Fava, M., Wisniewski, S.R., Lavori, P.W., Trivedi, M.H., Sackeim, H.A., et al. (2004). Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25, 119-142.
6. Rush, A.J., Kraemer, H.C., Sackeim, H.A., Fava, M., Trivedi, M.H., Frank, E., et al. (2006). Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology, 31, 1841-1853.
7. Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Stewart, J.W., Nierenberg, A.A., Thase, M.E., et al. (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine, 354, 1231-1242.
8. Thase, M.E., Friedman, E.S., Biggs, M.M., Wisniewski, S.R., Trivedi, M.H., Luther, J.F., et al. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. American Journal of Psychiatry, 164, 739-752.
9. Trivedi, M.H., Fava, M., Wisniewski, S.R., Thase, M.E., Quitkin, F., Warden, D., et al. (2006). Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine, 354, 1243-1252.
10. Trivedi, M.H., Rush, A.J., Gaynes, B.N., Stewart, J.W., Wisniewski, S.R., Warden, D., et al. (2007). Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology, 32, 2479-2489.
11. Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28-40.
12. Wisniewski, S.R., Fava, M., Trivedi, M.H., Thase, M.E., Warden, D., Niederehe, G., et al. (2007). Acceptability of second-step treatments to depressed outpatients: A STAR*D report. American Journal of Psychiatry, 164, 753-760.